News | July 09, 2009

Sorin Group’s Smallest Implantable Dual-Chamber Pacemaker Now Available in Canada

July 9, 2009 – Sorin Group said this week Health Canada cleared the REPLY family of dual- and single-chamber rate adaptive pacemakers.

The REPLY pacemaker is the world’s smallest dual chamber pacemaker at only 8 cc’s with no compromise on longevity, the company said. REPLY integrates Sorin Group’s proprietary SafeR pacing mode, based on the proven AAISafeR pacing mode first introduced to North America in 2005. Designed to titrate ventricular pacing, SafeR switches from AAI to DDD in case of AV block detection, and has been shown to reduce unnecessary pacing in both sinus node disease and unselected AV block patients(1). The CAN-SAVE R trial, currently being conducted in 10 centers across Canada, demonstrated SafeR was able to reduce ventricular pacing to less than 1 percent in the overall population, ranging between zero percent in patients without AV block and 1 percent in patients with AV block(2) (median values).

In addition to SafeR, the REPLY pacemaker delivers enhanced software for advanced, automatic features such as SmartCheck, which lets the user automate follow up tests and provides comprehensive data reporting, analysis and recommendations.

Felix Ayala-Paredes, M.D., chief of electrophysiology services at CHUS-Fleurimont Hospital in Sherbrooke, Quebec, implanted the first REPLY pacemaker in Canada. “Recent device-based therapy guidelines highlight the new standard of care, which is to minimize unnecessary ventricular pacing,” he said. “The REPLY pacemaker was a good choice for this patient. I am confident that the SafeR algorithm will minimize ventricular pacing, and I am especially impressed with the combination of small size and longevity.”

1. Pioger G, Leny G., Nitzsche R; Ripart A. AAIsafeR Limits Ventricular Pacing in Unselected Patients. PACE 2007; 30: S66-S70.

2. Thibault B. et al. Impact of AV Conduction Disorders on SafeR Mode Performance. PACE 2009; 32: S231-S235.

For more information: www.sorin.com

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init